Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-Label, Randomized, Controlled, Multicenter Phase II Study of Kangfu Spray for the Prevention of Radiation-Induced Oral Mucositis in Patients With Oral Malignancies Undergoing Intensity-Modulated Radiotherapy

NCT07538934 is registered in ClinicalTrials.gov with YE ZHANG as lead sponsor.

NCT NCT07538934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07538934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-Label, Randomized, Controlled, Multicenter Phase II Study of Kangfu Spray for the Prevention of Radiation-Induced Oral Mucositis in Patients With Oral Malignancies Undergoing Intensity-Modulated Radiotherapy
Lead sponsor
YE ZHANG
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
October 1, 2029
Enrollment
140 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

oral malignancy, radiation-induced oral mucositis